Eli Lilly and Co
-
Health News
WeightWatchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
[ad_1] Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an…
Read More » -
Health News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
[ad_1] In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images…
Read More » -
Health News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
[ad_1] Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection…
Read More » -
Business
Novo Nordisk’s Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21,…
Read More » -
Business
Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in…
Read More » -
Health News
Cigna will cap how much insurance can spend on weight loss drugs as it tries to expand coverage
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21,…
Read More » -
Health News
Novo Nordisk shares jump 7% on promising weight loss trial results; Eli Lilly dips
[ad_1] Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 7% on Thursday, hitting a fresh record high…
Read More » -
Pics News
Novo Nordisk’s diabetes drug Ozempic slashed the risk of kidney disease progression in trial
[ad_1] This picture taken on October 23, 2023, shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in…
Read More » -
Pics News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
[ad_1] Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or…
Read More » -
Health News
Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in…
Read More »